DeepMind’s AlphaFold 3 represents a significant leap in protein folding prediction, outperforming previous methods and expanding its capabilities to include ligands, DNA, and RNA. This advancement enables the development of biorenewable materials, more resilient crops, accelerated drug design, and genomics research. The AI’s multitasking ability surpasses specialist models, suggesting a future where generalist AI could handle entire drug discovery processes.